Why does one third of diabetics ignore their medications at regular rates?
Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .Why does one third of diabetics ignore their medications at regular rates?
A British medical study found that one-third of diabetics do not take the drug because of the side effects. Researchers at the University of Surrey in Britain analyzed and studied more than 1.6 million type 2 diabetes patients, Treatments needed.
The study collected data from clinical trials and a number of observational studies to examine adherence rates for both dosage and injection doses.
The researchers found that those who had metformin, the most common medication for the treatment of type 2 diabetes, were the least likely to be regular in the prescribed dosage, compared to other drugs that treated the disease. It was found that 30% Metformin "is not taken compared to about 23% of glyclazid and 20% of pioglitazone.
The researchers stressed that it is interesting that drugs DPP4 enzyme, one of the drug classes was regularity in taking higher among other drug options.
The researchers believe that the variation in adherence rates is due in part to the side effects of the various drugs. Metformin often causes gastrointestinal symptoms such as diarrhea and flatulence. DPP4 inhibitors are less likely to cause any side effects .